1255MO A phase II safety and efficacy study of PM8002/BNT327 in combination with chemotherapy in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
Authors:
- Y-L. WuYWY-L. Wu
- Z. WangZWZ. Wang
- Y. ChengYCY. Cheng
- J. FangJFJ. Fang
- X. MengXMX. Meng
- Y. PanYPY. Pan
- H. ZhaoHZH. Zhao
- Y. ZhaoYZY. Zhao
- H. SuHSH. Su
- M. SunMSM. Sun
- T. ZhouTZT. Zhou
- P. DuanPDP. Duan
- 17 September 2024
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 35, S804